Acquisition highlights of Axio Biosolutions and a snapshot of its key metrics.

Founded in 2008, Axio Biosolutions operates in Health Tech industry. Initially focused on creating hemostatic solutions, the company has expanded its product offerings to serve both trauma and surgical care markets. Axio Biosolutions launched MaxioCel, an advanced chitosan-based wound care product, enhancing its portfolio for chronic wound management. Further extending its reach, the company expanded its operations to South America and the Middle East. Competing with companies such as Consure Medical and Zoplar.

Leo Mavely

Founded in 2008, Axio Biosolutions has raised 20.90 Mn+ in funding from a total number of 9 investors.

Axio Biosolutions – Total Funding, Funding Over Time, Funding By Rounds and More.

Funding highlights of Axio Biosolutions and a snapshot of its key metrics.

GVFL

RNT Capital

Chiratae Ventures

Omidyar Network

Accel

TrueScale Capital

Omidyar Network India

UC-RNT Fund

Investment highlights of Axio Biosolutions and a snapshot of its key metrics.

Axio Biosolutions - A Health Tech Funded Company Based Out Of Ahmedabad

Axio Biosolutions

A snapshot of highlights, scale, and metrics

An overview of key people in Axio Biosolutions.

A Health Tech Funded Company Based Out Of Ahmedabad

Axio Biosolutions - Financials, Revenue, P&L Statement, Balance Sheet, Cash Flow & More